ABBV AbbVie Inc.

ABBV AbbVie Inc.

Healthcare · Drug Manufacturers - General

Desk view

Watchingmedium conviction · entry <$195 — not entered
Basis Entry target
Updated

Market read

Scan convergence 1 scan as of 2026-08-14 1 bull converging

POC $223.56 · VWAP $221.52 · +13.0% vs 12m avg buyer

uptrend vol: normalgaps: overnight-shiftchurn: quiet as of

Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)

Coverage

3 related perspectives

Watchlists @biotech-scan

ABBV Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist ABBV belongs to, members best 30-day change first — ABBV highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

Decision history

3 scored calls · newest first · projection

How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.

Jun 27 sell n/a Profit target +2.0% complete
Jun 27 sell n/a Profit target +2.0% complete
May 23 sell n/a Momentum recovery exit +8.5% complete

Next earnings ABBV reports in 72 days Oct 29

Last report Jul 31

Reported the quarter ending 2026-06-30: revenue $16.99B, diluted EPS $2.03, net income $3.61B (SEC filing, revenue corroborated by the desk's provider cache). Across the print the stock moved -4.8% (close before → first close after).

full note →

Against street estimates

How ABBV's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 9 quarters · newest report Jul 31 · projection Aug 17

Result
Jul 31 3.613.65 GAAP ≠ +1.1%In line
Apr 29 2.672.65 GAAP ≠ -0.8%In line
Feb 4 2.652.71 GAAP ≠ +2.2%Beat
Oct 31 '25 1.781.86 GAAP ≠ +4.2%Beat
Jul 31 '25 2.912.97 GAAP ≠ +2.1%Beat
Apr 25 '25 2.402.46 GAAP ≠ +2.6%Beat
Jan 31 '25 2.122.16 GAAP ≠ +1.9%In line
Oct 30 '24 2.923.00 GAAP ≠ +2.8%Beat

News (last pull)

Headlines about ABBV from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 40 days ago · Jul 9

“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.

Types
Jul 31 Catalyst ABBV earnings
Jul 30 Catalyst ABBV earnings
Jul 25 Desk Move ABBV — bench-signals buy
Apr 27 Reference YOLO Playbook
Mar 24 Article Daily Actions